Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients.
D000276:Adjuvants, Immunologic / Q000494:pharmacology* / Q000627:therapeutic use; D000363:Agaricales / Q000737:chemistry*; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor; D016516:CD4-CD8 Ratio; D018450:Disease Progression; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D005936:Glucans / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000378:metabolism; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000517:prevention & control; D009367:Neoplasm Staging; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D015375:Receptors, Interleukin-2 / Q000378:metabolism
D000276:Adjuvants, Immunologic; D014408:Biomarkers, Tumor; D005936:Glucans; D015375:Receptors, Interleukin-2